Avanos Medical (AVNS) vs. Its Competitors Financial Review
Avanos Medical (NYSE: AVNS) is one of 28 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Avanos Medical to similar companies based on the strength of its risk, earnings, institutional ownership, valuation, dividends, analyst recommendations and profitability.
Volatility and Risk
Avanos Medical has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Avanos Medical’s competitors have a beta of 0.92, indicating that their average stock price is 8% less volatile than the S&P 500.
84.9% of Avanos Medical shares are held by institutional investors. Comparatively, 58.0% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 1.4% of Avanos Medical shares are held by company insiders. Comparatively, 10.3% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This is a breakdown of recent recommendations for Avanos Medical and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Avanos Medical Competitors||153||793||1408||73||2.58|
Avanos Medical currently has a consensus price target of $67.50, indicating a potential downside of 6.78%. As a group, “Surgical appliances & supplies” companies have a potential downside of 3.82%. Given Avanos Medical’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Avanos Medical has less favorable growth aspects than its competitors.
Valuation and Earnings
This table compares Avanos Medical and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Avanos Medical||$611.60 million||$79.30 million||30.81|
|Avanos Medical Competitors||$1.31 billion||$198.48 million||28.92|
Avanos Medical’s competitors have higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This table compares Avanos Medical and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Avanos Medical Competitors||-166.91%||-201.27%||-22.27%|
Avanos Medical competitors beat Avanos Medical on 7 of the 13 factors compared.
About Avanos Medical
Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.